Ftse Mib
33.324,73
-1,28%
DAX
19.060,31
-0,60%
S&P 500
5.916,98
0,40%
NASDAQ
18.987,47
1,04%
Bitcoin
92.301,85
-0,04%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Lineage Cell Therapeutics Inc (LCTX) Lineage Cell Therapeutics Inc (LCTX) Notizie

Lineage Cell Therapeutics Inc

LCTX
0,92
0,0407 (4,63%)
20 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:10EDGAR2Form 8-K - Current report
14/11/202422:01BWLineage Cell Therapeutics Reports Third Quarter 2024..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202414:00BWLineage Cell Therapeutics to Report Third Quarter 2024..
14/10/202414:00BWLineage Cell Therapeutics to Present at the Maxim Group 2024..
25/9/202414:00BWOpRegen® (RG6501) Phase 1/2a Results to Be Featured at..
18/9/202414:00BWLineage Presents Preclinical Data on Its Auditory Neuronal..
20/8/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:10EDGAR2Form 8-K - Current report
14/6/202423:00EDGAR2Form 8-K - Current report
13/6/202422:30EDGAR2Form 8-K - Current report
28/5/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/5/202422:39EDGAR2Form 8-K - Current report
14/5/202422:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:10EDGAR2Form 8-K - Current report
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:17EDGAR2Form S-3 - Registration statement under Securities Act of..
07/3/202422:10EDGAR2Form 8-K - Current report
15/2/202423:27EDGAR2Form 8-K - Current report
13/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202400:57EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202415:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/2/202415:20EDGAR2Form 8-K - Current report
06/2/202415:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,8796 Min: 0,8794 Max: 0,9132
Chiusura: 0,8793

La tua Cronologia

AMEX
LCTX
Lineage Cell Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network